Bortezomib 1.3 / Daratumumab 16 / Dexamethasone (20/20), Multiple Myeloma, Cycle 1
Protocol-ID: 817 V2.1 (Mini), BORT1.3/DRTM16/DEXA(20/20), MM, C1Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 15.04.2021